Open Government Portal

Found 2972 records

After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review MELATONIN N-acetyl-5-methoxytryptamine review of safety Melatonin-use in Children-and-Adolescents neurological side effects anxiety panic reaction visual hallucinations seizures

Health Canada carried out a safety review to investigate the potential risk of developing an abnormal heart rhythm (QT interval …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Loratadine Abnormal heart rhythm QT interval prolongation use of over-the-counter drug products

Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Levetiracetam Methotrexate assessing potential risk Drug-Drug Interaction

Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Lanoxin Toloxin Apo-digoxin PMS-digoxin Digoxin assessing potential higher risk risk of Death

Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review KEPPRA levetiracetam assessing potential risk Acute Kidney Injury Acute renal failure Interstitial nephritis

A safety review was carried out to evaluate the potential risk of Raynaud's phenomenon in patients taking Intuniv XR. Raynaud's …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review INTUNIV XR guanfacine hydrochloride assessing potential risk Raynaud's Phenomenon disorder of the blood vessels fingers and toes enough blood-and-oxygen lack of blood-and-oxygen pale skin bluish colour skin ...

As part of Health Canada's ongoing monitoring of glistening development in IOLs, Health Canada reviewed the available safety information related …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Intraocular lenses assessing potential risk small pockets liquid in intraocular-lenses glistening

A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that the use …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Hydroxyzine ATARAX assessing potential risk abnormal heart rhythm abnormal changes electrical-activity of the-heart QT interval prolongation

It is known that hydrocodone can slow breathing when too much is taken. The labelling for these drugs already warns …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Hydrocodone-containing products assessing risk slow breathing Serious-Breathing-Problems respiratory depression

Health Canada reviewed the potential risk of liver injury with green tea extract-containing natural health products because of ongoing reports …

Record Modified: May 9, 2024
Record Released: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Green tea extract natural health products assessing potential risk liver injury hepatotoxicity